2013-12 | Juvenile parkinsonism as an initial manifestation of gliomatosis cerebri | 김승현 |
2012-06 | Lipopolysaccharide-mediated protein expression profiling on neuronal differentiated SH-SY5Y cells | 김승현 |
2020-01 | Lithium as a Treatment for Alzheimer’s Disease: The Systems Pharmacology Perspective | 김승현 |
2016-07 | Mesenchymal Stem Cells Modulate the Functional Properties of Microglia via TGF-beta Secretion | 김승현 |
2011-01 | Microbleeds and free active MMP-9 are independent risk factors for neurological deterioration in acute lacunar stroke | 김승현 |
2014-10 | Mutations in UBQLN2 and SIGMAR1 genes are rare in Korean patients with amyotrophic lateral sclerosis | 김승현 |
2014-08 | Mutations in UBQLN2 and SIGMAR1 genes are rare in Korean patients with amyotrophic lateral sclerosis | 김승현 |
2020-05 | N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer’s disease | 김승현 |
2013-12 | Neural Induction With Neurogenin 1 Enhances the Therapeutic Potential of Mesenchymal Stem Cells in an Amyotrophic Lateral Sclerosis Mouse Model | 김승현 |
2018-04 | Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer's Disease | 김승현 |
2016-04 | Neuroprotective and antioxidant activities of bamboo salt soy sauce against H2O2-induced oxidative stress in rat cortical neurons | 김승현 |
2012-09 | The neuroprotective effect of the GSK-3 beta inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice | 김승현 |
2017-06 | Neuroprotective effects of a novel poly (ADP-ribose) polymerase-1 inhibitor, JPI-289, in hypoxic rat cortical neurons | 김승현 |
2013-05 | Neuroprotective effects of donepezil against A beta 42-induced neuronal toxicity are mediated through not only enhancing PP2A activity but also regulating GSK-3 beta and nAChRs activity | 김승현 |
2014-05 | Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis | 김승현 |
2017-01 | Neuroregenerative potential of intravenous G-CSF and autologous peripheral blood stem cells in children with cerebral palsy: a randomized, double-blind, cross-over study | 김승현 |
2013-05 | Newly developed glycogen synthase kinase-3 (GSK-3) inhibitors protect neuronal cells death in amyloid-beta induced cell model and in a transgenic mouse model of Alzheimer's disease | 김승현 |
2011-04 | A novel codon4 mutation (A4F) in the SOD1gene in familial amyotrophic lateral sclerosis | 김승현 |
2012-03 | A Novel Exon 3 Mutation (P66S) in the SOD1 Gene in Familial ALS | 김승현 |
2015-10 | A Novel F45S SOD1 Mutation in Amyotrophic Lateral Sclerosis Coexisting with Bullous Pemphigoid | 김승현 |
2015-01 | De novo FUS mutations in 2 Korean patients with sporadic amyotrophic lateral sclerosis | 김승현 |
2016-10 | Patient fibroblasts-derived induced neurons demonstrate autonomous neuronal defects in adult-onset Krabbe disease | 김승현 |
2015-07 | A Phase 1/2 Study for Safety and Efficacy Evaluation of Treatment of Amyotrophic Lateral Sclerosis Using Autologous Bone-Marrow-Derived Stromal Cell | 김승현 |
2015-05 | Phase I Trial of Repeated Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis | 김승현 |
2018-06 | Precision medicine and drug development in Alzheimer's disease: the importance of sexual dimorphism and patient stratification | 김승현 |
2017-07 | Prognosis of Patients with Behavioral Variant Frontotemporal Dementia Who have Focal Versus Diffuse Frontal Atrophy | 김승현 |
2015-10 | Prognostic Role of Serum Levels of Uric Acid in Amyotrophic Lateral Sclerosis | 김승현 |
2017-10 | Quantitative susceptibility mapping of the motor cortex: a comparison of susceptibility among patients with amyotrophic lateral sclerosis, cerebrovascular disease, and healthy controls | 김승현 |
2017-12 | The Rap activator Gef26 regulates synaptic growth and neuronal survival via inhibition of BMP signaling | 김승현 |
2014-10 | Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis: A Pilot Study of Safety and Feasibility | 김승현 |